Prognostic Factors in Malignant Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: A Baseline Risk Score

被引：0
|
作者：
Guijosa, A. [1 ]
Munoz-Montano, W. [1 ]
Trejo-Rosales, R. [2 ]
Gomez-Garcia, A. P. [1 ]
Cabrera-Miranda, L. A. [1 ]
Flores, D. [1 ]
Arrieta, O. [1 ]
机构：
[1] Natl Canc Inst Mexico INCan, Mexico City, DF, Mexico
[2] Natl Med Ctr, Century XXI, IMSS, Mexico City, DF, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Mesothelioma; Prognosis; Chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.14A.02
引用
收藏
页码：S684 / S684
页数：1
相关论文
共 50 条
  • [21] Liposomal doxorubicin and cisplatin as first-line chemotherapy in unresectable malignant pleural mesothelioma: A phase II study
    Arrieta, Oscar
    Medina, Luis A.
    Guzman, Enrique
    Rios-Trejo, Miguel A.
    Villanueva, Geraldine
    Mendoza, Daniel
    Astorga-Ramos, Alma M.
    Martinez-Barrera, Luis
    Hernandez-Pedro, Norma
    Arechaga-Ocampo, Elena
    de la Garza, Jamie
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S779 - S779
  • [22] Prognostic factors of the loss of autonomy (LoA) in older patients with cancer receiving first-line chemotherapy.
    Soubeyran, Pierre-Louis
    Fonck, Marianne
    Hoppenreys, Laurent
    Hoppe, Stephanie
    Bellera, Carine
    Blanc-Bisson, Christele
    Blanc, Jean-Frederic
    Ceccaldi, Joel
    Mertens, Cecile
    Imbert, Yves
    Cany, Laurent
    Vogt, Luc
    Dauba, Jerome
    Houede, Nadine
    Floquet, Anne
    Chomy, Francois
    Brouste, Veronique
    Ravaud, Alain
    Mathoulin-Pelissier, Simone
    Rainfray, Muriel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Physician's Choice of First-line Platinum Chemotherapy
    Kerrigan, K.
    Chipman, J.
    Jo, Y. J.
    Haaland, B.
    Johnson, E.
    Puri, S.
    Varghese, T.
    Akerley, W.
    Patel, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S122 - S123
  • [24] Malignant Pleural Mesothelioma: First Chemotherapy or first Surgery?
    Lorenz, Judith
    ZENTRALBLATT FUR CHIRURGIE, 2019, 144 (03):
  • [25] STELLAR - Final Results of a Phase 2 Trial of TTFields with Chemotherapy for First-Line Treatment of Malignant Pleural Mesothelioma
    Ceresoli, G.
    Aerts, J.
    Madrzak, J.
    Dziadziuszko, R.
    Ramlau, R.
    Cedres, S.
    Hiddinga, B.
    Van Meerbeeck, J.
    Mencoboni, M.
    Planchard, D.
    Chella, A.
    Crino, L.
    Krzakowski, M.
    Grosso, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S397 - S398
  • [26] STELLAR Trial: Radiological Response Patterns of TTFields Plus Chemotherapy in First-Line Treatment of Malignant Pleural Mesothelioma
    Grosso, F.
    Aerts, J.
    Ramlau, R.
    Cedres, S.
    Mencoboni, M.
    Van Meerbeeck, J.
    Dziadziuszko, R.
    Planchard, D.
    Chella, A.
    Crino, L.
    Krzakowski, M.
    Ceresoli, G. L.
    Weinberg, U.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S755 - S755
  • [27] First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma
    Fujimoto, Eriko
    Kijima, Takashi
    Kuribayashi, Kozo
    Negi, Yoshiki
    Kanemura, Shingo
    Mikami, Koji
    Doi, Hiroshi
    Kitajima, Kazuhiro
    Nakano, Takashi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (09) : 865 - 872
  • [28] First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma
    Fujimoto, E.
    Kuribayashi, K.
    Kanemura, S.
    Negi, Y.
    Koda, Y.
    Mikami, K.
    Minami, T.
    Yokoi, T.
    Nakano, T.
    Kijima, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Biomarkers and prognostic factors for malignant pleural mesothelioma
    Vigneri, Paolo
    Martorana, Federica
    Manzella, Livia
    Stella, Stefania
    FUTURE ONCOLOGY, 2015, 11 (24) : 29 - 33
  • [30] PROGNOSTIC FACTORS AND SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
    VANGELDER, T
    DAMHUIS, RAM
    HOOGSTEDEN, HC
    EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (06) : 1035 - 1038
12345